Neurological gait disorders.
Conditions
Interventions
The participants will be randomly assigned into two groups: control group and intervention group.
The subjects of the control group will be submitted to a conservative treatment protocol that will co
Other
E02.779
E02.760.169.063.500.387
Sponsors
Universidade Federal de São Paulo
Instituto de Assistência ao Servidor Público Estadual de São Paulo
Eligibility
Age
5 Years to 11 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria will be: children between 5 and 11 years of age; of both sexes; diagnosed with idiopathic toe walking; that present gait in equine; with bilateral involvement and that do not present any neurological or psychiatric impairment.
Exclusion criteria
Exclusion criteria: The exclusion criteria will be: children under 5 years and over 11 years of age; with structural ankle deformity in equine (inability to reach the ankle neutral position passively); with central or peripheral neurological impairment; who are unable to minimally understand the questions used during the evaluations; which have undergone surgery in the lower limbs or who have undergone the application of botulinum toxin in the last 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the active range of motion of ankle dorsiflexion, assessed by a two-dimensional kinematic analysis of the sagittal plane. The kinematic evaluation will be performed using a video recording in the sagittal plane of the lower limbs, using a GoPro Hero 4 camera, configured with a rate of 240 fps with 720p image quality in narrow mode. The most affected side (with a lower amplitude of dorsiflexion) will be used to compare the groups. Two-dimensional kinematics will be performed at baseline and at the end of treatment (8 weeks). A mean difference of 6.29 degrees of the amplitude of ankle dorsiflexion will be taken as the basis for establishing clinical significance. Such a difference is expected between the beginning and the end of the treatment and between groups, to affirm that the intervention group was superior to the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will be the static and dynamic balance, measured by the KTK test, the passive range of motion, measured by the lunge-test and the Ped4.0 quality of life questionnaire. The KTK test for static and dynamic balance and the lunge-test for passive range of motion assessment will be applied at the baseline and at the end of treatment (8 weeks). The Ped4.0 quality of life questionnaire will be applied at the baseline, at the end of treatment (8 weeks) and 24 weeks after the baseline (follow-up). It is expected that the intervention group had superior results to the control group in all variables analyzed. | — |
Countries
Brazil
Contacts
Public ContactVanessa de Oliveira
Universidade Federal de São Paulo
Outcome results
None listed